Category

• Business1
• Pipeline1

Organizations

• Bausch + Lomb61
• Eyes On Eyecare42
• Alcon, Inc.39
• American Optometric Association34
• Harrow26
• Glaukos25
• Aldeyra Therapeutics20
• Regeneron20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Clinical Trials2
• Myopia2
• Myopia Management2
• CEO1
• FDA1
• Eye Drop Solution1
• Eye Drops1
• Pediatrics1

• Organizations: Sydnexis ✕

Clear all

Pipeline

FDA accepts NDA for Sydnexis's low-dose atropine for pediatric myopia

Once-daily drop features unique establishing excipient to avoid rapid atropine degradation; may become first eye drop with 3-year shelf-life.

Business

Sydnexis names long-time industry executive as new leader

Effective Aug. 5, Perry J. Sternberg will take over as CEO of the pediatric myopia-focused pharmaceutical company.